Triple-negative breast cancer is one of the most aggressive and difficult forms of breast cancer to treat. Unlike many other types of breast cancer,...
Vous n'êtes pas connecté
Maroc - KNOWRIDGE.COM - A La Une - 16/Mar 23:40
Cancer remains one of the most serious health challenges in the world. It occurs when cells in the body begin to grow uncontrollably and form tumors that can spread to other organs. Although modern medicine has developed many treatments, including surgery, chemotherapy, radiation therapy, and immunotherapy, many cancers are still difficult to treat, especially when […] The post New vaccine may help prevent multiple cancers appeared first on Knowridge Science Report.
Triple-negative breast cancer is one of the most aggressive and difficult forms of breast cancer to treat. Unlike many other types of breast cancer,...
Triple-negative breast cancer is one of the most aggressive and difficult forms of breast cancer to treat. Unlike many other types of breast cancer,...
Liver cancer is one of the most dangerous cancers in the world, and doctors have been searching for better ways to prevent it for many years. Now, a...
Liver cancer is one of the most dangerous cancers in the world, and doctors have been searching for better ways to prevent it for many years. Now, a...
A vaccine that is usually given to prevent shingles may have another surprising benefit. New research suggests that it might also help slow the aging...
A vaccine that is usually given to prevent shingles may have another surprising benefit. New research suggests that it might also help slow the aging...
Engineers at the University of Pennsylvania have developed a new type of lipid nanoparticle (LNP) that could one day serve as a universal...
Engineers at the University of Pennsylvania have developed a new type of lipid nanoparticle (LNP) that could one day serve as a universal...
A common medicine used to treat weak bones may also help protect the brain, according to a new large study from researchers at the University of Hong...
Results from the phase 3 KEYNOTE-B15 clinical trial found that the combination of the targeted therapy drug enfortumab vedotin with the immunotherapy...